Nucleis Radiopharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Nucleis Radiopharmaceuticals General Information
Description
Manufacturer of diagnostic tools and medicines designed to assist the emergence of medicinal therapies in clinical oncology, cardiology, neurology, and infectious/inflammatory diseases. The company offers GMP-compliant radiopharmaceutical production for nuclear and non-nuclear medical imaging, enabling healthcare providers and medical imaging facilities to access reliable imaging materials for accurate clinical evaluation.
Contact Information
Website
www.nucleis.euCorporate Office
- Allée du Six-Août 8
- 4000 Liege
- Belgium
Corporate Office
- Allée du Six-Août 8
- 4000 Liege
- Belgium
Nucleis Radiopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nucleis Radiopharmaceuticals Signals
Nucleis Radiopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nucleis Radiopharmaceuticals FAQs
-
When was Nucleis Radiopharmaceuticals founded?
Nucleis Radiopharmaceuticals was founded in 2017.
-
Where is Nucleis Radiopharmaceuticals headquartered?
Nucleis Radiopharmaceuticals is headquartered in Liege, Belgium.
-
What is the size of Nucleis Radiopharmaceuticals?
Nucleis Radiopharmaceuticals has 15 total employees.
-
What industry is Nucleis Radiopharmaceuticals in?
Nucleis Radiopharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Nucleis Radiopharmaceuticals a private or public company?
Nucleis Radiopharmaceuticals is a Private company.
-
What is Nucleis Radiopharmaceuticals’s current revenue?
The current revenue for Nucleis Radiopharmaceuticals is .
-
How much funding has Nucleis Radiopharmaceuticals raised over time?
Nucleis Radiopharmaceuticals has raised $2.64M.
-
Who are Nucleis Radiopharmaceuticals’s investors?
Noshaq and Société Fédérale de Participations et d'Investissement have invested in Nucleis Radiopharmaceuticals.
-
When was Nucleis Radiopharmaceuticals acquired?
Nucleis Radiopharmaceuticals was acquired on 10-Apr-2025.
-
Who acquired Nucleis Radiopharmaceuticals?
Nucleis Radiopharmaceuticals was acquired by Curium Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process